UPDATE 1-Paladin to buy some products from Wyeth
* Financial terms of deal not disclosed
* Sees deal boosting OTC portfolio
June 29 (Reuters) - Paladin Labs Inc PLB.TO said it agreed to buy a bundle of products currently marketed in Canada by U.S. drugmaker Wyeth WYE.N for an undisclosed amount to boost its over-the-counter portfolio.
The specialty pharmaceutical company said Canadian net sales of the portfolio of products was about C$4 million ($3.46 million) for 2008.
Shares of the Montreal-based company closed at C$18.90 Friday on the Toronto Stock Exchange. ($1=1.155 Canadian Dollar) (Reporting by Anurag Kotoky in Bangalore; Editing by Deepak Kannan)
© Thomson Reuters 2017 All rights reserved.